甲基胺促进前端对象主导的大脑状态,改善认知表现:一项随机试验
Weizheng Yan1, Şükrü Barış Demiral2, Dardo Tomasi2
1National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD 20892, USA. weizheng.yan@nih.gov nvolkow@nida.nih.gov.
概括
甲基化物 (MP) 通过改变大脑状态来增强注意力,特别是促进前端对象网络. 这种效应与多巴胺D1受体的可用性和在不那么苛刻的任务上提高性能有关.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 认知科学 认知科学
背景情况:
- 甲基 (MP) 是ADHD的兴奋剂,增强多巴胺信号传递.
- 它对注意力大脑状态动态的确切影响尚不清楚.
- 鉴于其作为认知增强剂的用途,了解MP的影响至关重要.
研究的目的:
- 研究MP如何改变大脑状态动态和多巴胺信号传递.
- 为了将这些变化与健康成年人的认知表现相关联.
- 探索多巴胺受体在MP影响中的作用.
主要方法:
- 多模式神经成像 (PET,fMRI) 和行为任务.
- 在MP施用前和施用后对大脑状态的动态功能分析.
- 与纹状D1和D2多巴胺受体可用性的相关性分析.
主要成果:
- MP改变了前对象主导激活 (FPN+),体运动主导激活 (SOM+) 和视觉主导抑制 (VIS-) 的大脑状态.
- 在FPN+和VIS-中增加了停留时间,在SOM+中减少了.
- FPN+停留时间与D1受体可用性相关,并改善了简单任务的性能.
结论:
- 通过D1R信号传输,MP通过调节大脑状态 (促进FPN+,VIS-;减少SOM+) 来提高注意力.
- 这种机制是健康个体对不那么苛刻的任务更好的关注的基础.
- 该研究引入了一种多式联络方法,用于预测个人对MP的反应.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
87
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
87
01:30Attention-Deficit/Hyperactivity Disorder
34
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34